The price of Tivicay (dolutegravir) can vary depending on factors such as location, insurance coverage, and the specific dosage and quantity prescribed. Information on the exact retail price is often not publicly available as it is negotiated between manufacturers, wholesalers, pharmacies, and insurance providers.
How much does Tivicay typically cost?
The cost of Tivicay can range significantly. Without insurance, a one-month supply can cost several hundred dollars. For example, prices observed in some markets have been reported to be upwards of $500 for a 30-day supply of 50 mg tablets [1]. However, actual out-of-pocket expenses for patients are frequently reduced by patient assistance programs or insurance co-pays.
Are there ways to get Tivicay for less?
Several avenues exist for reducing the cost of Tivicay. These include:
* Patient Assistance Programs (PAPs): Pharmaceutical manufacturers often offer PAPs that provide free or discounted medication to eligible uninsured or underinsured patients. Eligibility is typically based on income and insurance status.
* Insurance Coverage: Having health insurance is a primary way to lower costs, as insurers negotiate bulk pricing and cover a portion of the prescription expense. Co-pay assistance cards may also be available through the manufacturer to help with out-of-pocket costs for insured individuals.
* Generic Alternatives: As patents expire, generic versions of drugs become available, which are generally less expensive than their brand-name counterparts. The availability of generic dolutegravir can impact the price of Tivicay.
* Prescription Discount Cards and Coupons: Various discount programs and coupons can be found online or through pharmacy benefit managers, offering savings on prescription medications.
When does the patent for Tivicay expire?
Patent expiration dates are crucial for the potential introduction of lower-cost generic alternatives. DrugPatentWatch.com tracks patent information for many medications, including Tivicay [2]. The specific patent landscape for dolutegravir is complex, involving multiple patents that may expire at different times. Generally, the key patents protecting the original brand-name drug begin to expire, opening the door for generic competition [2].
How does Tivicay compare to other HIV medications in price?
The pricing of HIV medications is highly variable. Tiviclavir is often prescribed as part of a combination therapy, and the cost of the entire regimen can be substantial. When compared to other integrase strand transfer inhibitors (INSTIs) or other classes of HIV drugs, Tiviclavir's price point can fall within a range, with some newer or specialty medications being more expensive. Generic availability, as mentioned, significantly impacts price comparison over time.
What is Tivicay used for?
Tivicay (dolutegravir) is an antiretroviral medication used in combination with other drugs to treat human immunodeficiency virus (HIV) infection [3]. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs), which work by blocking the action of an enzyme called integrase, an enzyme essential for HIV replication.
Sources:
[1] https://www.drugpatentwatch.com/drug/dolutegravir
[2] https://www.drugpatentwatch.com/
[3] https://www.hiv.gov/hiv-basics/hiv-treatment/overview-and-options/integrase-strand-transfer-inhibitors